HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chris G Parsons Selected Research

MRZ 2-576

7/2006The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chris G Parsons Research Topics

Disease

12Alzheimer Disease (Alzheimer's Disease)
09/2017 - 09/2003
3Pain (Aches)
12/2012 - 08/2004
2Hyperalgesia
12/2012 - 08/2004
2Stroke (Strokes)
01/2007 - 03/2002
1Memory Disorders (Memory Loss)
05/2011
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2007
1Encephalitis (Encephalitis, Rasmussen)
09/2006
1Dementia (Dementias)
09/2006
1Neurodegenerative Diseases (Neurodegenerative Disease)
09/2006
1Neuralgia (Stump Neuralgia)
07/2006
1Mental Disorders (Mental Disorder)
06/2006
1Partial Epilepsies (Epilepsy, Partial)
06/2006
1Seizures (Absence Seizure)
06/2006
1Chronic Pain
08/2004
1Hypoxia (Hypoxemia)
01/2004
1Disease Progression
09/2003
1Inflammation (Inflammations)
09/2003
1Wounds and Injuries (Trauma)
03/2002

Drug/Important Bio-Agent (IBA)

10N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
09/2017 - 09/2003
8Memantine (Namenda)FDA Link
10/2013 - 09/2003
5Amyloid beta-PeptidesIBA
09/2017 - 09/2003
5Glutamic Acid (Glutamate)FDA Link
09/2012 - 09/2003
4N-Methylaspartate (NMDA)IBA
09/2017 - 08/2004
2Amyloid (Amyloid Fibrils)IBA
09/2017 - 09/2012
2Peptides (Polypeptides)IBA
05/2017 - 09/2012
2Formaldehyde (Formol)FDA Link
12/2012 - 08/2004
2methanesulfonic acid (methanesulfonate)IBA
01/2007 - 06/2006
2pyridineIBA
01/2007 - 06/2006
1Proteins (Proteins, Gene)FDA Link
09/2017
1Cholinesterase Inhibitors (Anticholinesterases)IBA
10/2013
1gamma-Aminobutyric Acid (GABA)IBA
12/2012
1L 838,417IBA
12/2012
13'- (5- (1- hydroxy- 1- methylethyl)benzoimidazol- 1- yl)biphenyl- 2- carbonitrileIBA
12/2012
1Cholinergic Agents (Cholinergics)IBA
11/2012
1MRZ 2-576IBA
07/2006
1KetamineFDA LinkGeneric
07/2006
1Anticonvulsants (Antiepileptic Drugs)IBA
06/2006
1Opioid Analgesics (Opioids)IBA
08/2004
1Dizocilpine Maleate (Dizocilpine)IBA
08/2004
1Glutamate Receptors (Glutamate Receptor)IBA
08/2004
1MagnesiumIBA
09/2003
1Neuroprotective AgentsIBA
03/2002
1remacemideIBA
03/2002
1CNS 5161IBA
03/2002
1neramexaneIBA
03/2002
1alpha-phenyl-2-pyridineethanamine dihydrochlorideIBA
03/2002
1HU 211 (HU 210)IBA
03/2002
15- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)IBA
03/2002

Therapy/Procedure

2Ligation
12/2012 - 08/2004
1Therapeutics
10/2013